Jinyan Liu|Yi Zhang - JoVE Visualize

Showing results (1-10 of 18,170) with videos related to

Pageof 1,817

Sort By:

Biomarker Research|June 1, 2022

Intratumor microbiome in cancer progression: current developments, challenges and future trendsJinyan Liu, Yi Zhang

European Journal of Immunology|December 17, 2023

Current advances in bacteria-based cancer immunotherapyCaijuan Guo, Jinyan Liu, Yi Zhang

Cancer Immunology, Immunotherapy : CII|September 29, 2025

Single-cell transcriptomic analyses provide insights into SPP1<sup>+</sup> TAM-mediated immune suppression and CD8<sup>+</sup> T cell dysfunction in lung cancerRahma Taher Almgrami, Tengyue Zhang, Qitai Zhao, et al.

Frontiers in Immunology|April 8, 2021

Indoleamine 2,3-Dioxygenase 1 Inhibitor-Loaded Nanosheets Enhance CAR-T Cell Function in Esophageal Squamous Cell CarcinomaJingwen Shao, Lin Hou, Jinyan Liu, et al.

Signal Transduction and Targeted Therapy|July 27, 2020

COVID-19: immunopathogenesis and ImmunotherapeuticsLi Yang, Shasha Liu, Jinyan Liu, et al.

Journal for Immunotherapy of Cancer|October 7, 2020

Point mutation in <i>CD19</i> facilitates immune escape of B cell lymphoma from CAR-T cell therapyZhen Zhang, Xinfeng Chen, Yonggui Tian, et al.

European Journal of Immunology|November 10, 2021

Immuno-oncological role of 20S proteasome alpha-subunit 3 in aggravating the progression of esophageal squamous cell carcinomaJinyan Liu, Jingwen Shao, Chaoqi Zhang, et al.

Cancer Immunology, Immunotherapy : CII|January 3, 2025

Distinct immune signatures for predicting the immunotherapy efficacy of esophageal squamous cell carcinoma or adenocarcinomaPeng Wu, Guohui Qin, Jinyan Liu, et al.

Signal Transduction and Targeted Therapy|April 27, 2023

Overcoming resistance to immunotherapy by targeting GPR84 in myeloid-derived suppressor cellsGuohui Qin, Shasha Liu, Jinyan Liu, et al.

Frontiers in Immunology|November 9, 2023

The safety and anti-tumor effect of multiple peptides-pulsed dendritic cells combined with induced specific cytotoxic T lymphocytes for patients with solid tumorsXuan Zhao, Zhen Zhang, Chunli Wen, et al.

Pageof 1,817

Showing results (1-10 of 18,170) with videos related to

Sort By:

Pageof 1,817

Biomarker Research|June 1, 2022

Intratumor microbiome in cancer progression: current developments, challenges and future trendsJinyan Liu, Yi Zhang

European Journal of Immunology|December 17, 2023

Current advances in bacteria-based cancer immunotherapyCaijuan Guo, Jinyan Liu, Yi Zhang

Cancer Immunology, Immunotherapy : CII|September 29, 2025

Single-cell transcriptomic analyses provide insights into SPP1<sup>+</sup> TAM-mediated immune suppression and CD8<sup>+</sup> T cell dysfunction in lung cancerRahma Taher Almgrami, Tengyue Zhang, Qitai Zhao, et al.

Frontiers in Immunology|April 8, 2021

Indoleamine 2,3-Dioxygenase 1 Inhibitor-Loaded Nanosheets Enhance CAR-T Cell Function in Esophageal Squamous Cell CarcinomaJingwen Shao, Lin Hou, Jinyan Liu, et al.

Signal Transduction and Targeted Therapy|July 27, 2020

COVID-19: immunopathogenesis and ImmunotherapeuticsLi Yang, Shasha Liu, Jinyan Liu, et al.

Journal for Immunotherapy of Cancer|October 7, 2020

Point mutation in <i>CD19</i> facilitates immune escape of B cell lymphoma from CAR-T cell therapyZhen Zhang, Xinfeng Chen, Yonggui Tian, et al.

European Journal of Immunology|November 10, 2021

Immuno-oncological role of 20S proteasome alpha-subunit 3 in aggravating the progression of esophageal squamous cell carcinomaJinyan Liu, Jingwen Shao, Chaoqi Zhang, et al.

Cancer Immunology, Immunotherapy : CII|January 3, 2025

Distinct immune signatures for predicting the immunotherapy efficacy of esophageal squamous cell carcinoma or adenocarcinomaPeng Wu, Guohui Qin, Jinyan Liu, et al.

Signal Transduction and Targeted Therapy|April 27, 2023

Overcoming resistance to immunotherapy by targeting GPR84 in myeloid-derived suppressor cellsGuohui Qin, Shasha Liu, Jinyan Liu, et al.

Frontiers in Immunology|November 9, 2023

The safety and anti-tumor effect of multiple peptides-pulsed dendritic cells combined with induced specific cytotoxic T lymphocytes for patients with solid tumorsXuan Zhao, Zhen Zhang, Chunli Wen, et al.

Pageof 1,817